GET DAILY SIGNALSMedical Properties Trust (MPT) Q3 2026 Earnings: Watching the Recovery Take Shape
Key Takeaways
- Medical Properties Trust (MPT) is scheduled to report third-quarter 2026 results for the period ended September 30, 2026, with consensus revenue near $255 million and normalized FFO (funds from operations, a standard real estate profitability measure) around $0.13 to $0.14 per share.
- The report represents another milestone in MPT's multi-year effort to stabilize rent collections and repair its balance sheet following the bankruptcies of major tenants Steward Health Care and Prospect Medical Holdings.
- Analyst sentiment remains cautious, with a consensus price target near $5.13 versus a share price around $2.75 and a market capitalization of roughly $1.64 billion.
- Investors will focus on rent collection from replacement operators, progress toward more than $1 billion in annualized cash rent, and coverage of the $0.09 quarterly dividend.
Why This Earnings Report Matters
Medical Properties Trust is one of the world's largest owners of hospital real estate, with roughly 380 facilities and about 38,000 licensed beds across nine countries. The company has spent recent years recovering from the bankruptcies of two of its largest tenants, a period marked by impairments, missed rent, and a sharply lower share price. The third-quarter report matters because it will show whether replacement operators are paying rent on schedule and whether MPT can sustain momentum toward its stated goal of exceeding $1 billion in annualized cash rent by the end of 2026. For a REIT, the ability to reliably collect rent and cover its dividend is the central test of financial health. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
What Analysts Are Expecting
For the quarter ended September 30, 2026, analysts expect revenue of roughly $254.6 million to $256.9 million and normalized FFO near $0.13 to $0.14 per share. GAAP earnings per share are expected near breakeven, around -$0.01. This compares with the third quarter of 2025, when MPT reported a GAAP loss of $0.13 per share on revenue of $237.5 million.
In the most recent quarter, MPT reported normalized FFO of $0.15 per share, up from $0.14 in the first quarter, with revenue of $259.3 million that exceeded forecasts. The company has beaten consensus FFO estimates in only a few of the past seven quarters, underscoring the execution risk surrounding tenant transitions. On guidance, management has said it expects monthly rent and interest receipts to increase through contractual escalations and re-tenanting activity, while anticipating no material new real estate investments in the near term.
How the Market Is Viewing MPT
MPT shares trade near $2.75, just above a 52-week low of about $2.73 and roughly 50% below their 52-week high, reflecting persistent investor skepticism about the pace of the turnaround. Eight analysts rate the stock neutral on average, with three buy ratings, three holds, and two sells. Estimate revisions have been largely flat to slightly lower over recent months, signaling a wait-and-see posture rather than growing optimism. Key risk factors heading into the report include rent collection from replacement operators, concerns around Texas Medicaid funding for certain hospital tenants, and elevated leverage, all of which could weigh on sentiment if results or commentary disappoint.
What to Watch After the Report
Following the report, investors should watch several items that will shape MPT's trajectory. First is rent collection from replacement tenants. Management has indicated that certain operators are expected to return to full rent payments on staggered timelines, so any confirmation or slippage in those schedules will be closely read.
Second is progress toward the $1 billion annualized cash rent target. Reaching that milestone would mark a meaningful step in stabilizing cash flow and supporting the $0.09 quarterly dividend, which management has maintained through the recovery.
Third is the balance sheet. MPT recently completed a roughly $2.4 billion refinancing that extends major debt maturities to 2032, reducing near-term refinancing pressure. Commentary on further asset sales and deleveraging will indicate how management plans to lower leverage over time.
Finally, tenant credit quality remains a key watch item. Because several replacement operators face their own financial pressures, any new signs of missed payments or restructuring would be significant. While the company's metrics point toward a gradual recovery, execution on rent collection, cost control, and portfolio stabilization will ultimately determine whether the turnaround gains traction.
Supporting My Research with Tickeron Tools
In preparing for earnings like these, I often rely on Tickeron’s AI Screener to quickly compare MPT against peers and spot relevant patterns across the healthcare REIT space. The tool helps surface ideas based on fundamentals and technical signals without replacing my own analysis, and it has become a regular part of how I organize thoughts ahead of reports like this one.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MPT's RSI Indicator sits in oversold zone for 10 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
MPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MPT as a result. In 63 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.
The Moving Average Convergence Divergence Histogram (MACD) for MPT turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for MPT entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.349) is normal, around the industry mean (3.096). MPT has a moderately low P/E Ratio (-52.600) as compared to the industry average of (28.164). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.649). MPT's Dividend Yield (0.137) is considerably higher than the industry average of (0.048). P/S Ratio (1.994) is also within normal values, averaging (6.013).
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. MPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PublishingBooksMagazines
Advertisement